Overview

A Drug to Drug Interaction Study of Sotagliflozin With Hydrochlorothiazide

Status:
Completed
Trial end date:
2018-03-02
Target enrollment:
Participant gender:
Summary
Primary Objective: To assess the effects of multiple-dose hydrochlorothiazide (HCTZ) on the steady-state pharmacokinetics (PK) of sotagliflozin. Secondary Objectives: - To assess the safety and tolerability of multiple-dose sotagliflozin with and without co-administration of multiple-dose HCTZ - To assess the effects of multiple-dose sotagliflozin on the steady-state PK of HCTZ - To assess the effects of multiple-dose HCTZ on the steady-state PK of sotagliflozin-3-O-glucuronide
Phase:
Phase 1
Details
Lead Sponsor:
Sanofi
Treatments:
(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol
Hydrochlorothiazide